Exclusive: Flagship's Abiologics uses AI to build mirror-image proteins for new drugs
Flagship Pioneering's Abiologics emerged from stealth, using AI to design mirror-image proteins as a new modality for drug development.
Abiologics
Private
Profile of Abiologics created from news harvest. To be enriched by user.
Company Info
Sector:Biotech / Mirror-image proteins / AI drug discovery
Headquarters:Cambridge, Massachusetts, USA
Founded:2024
Website:www.abiologics.com/
Clinical Development Pipeline
Undisclosed
Target: TBDRecent News
Leadership Team
Avak Kahvejian, Ph.D.
Co-Founder and Chief Executive Officer
Careers & Job Openings
No active job listings. Check back later.